Press Release

18.01.2018

New BMBF-funded research project aims at validation of micro RNAs as therapeutic targets

Over the next two years, Germany’s Federal Ministry of Education and Research (BMBF) will provide one million euros in funding for the ComboMiR project. The aim of the research is to target microRNAs to develop new therapeutic approaches to metabolic diseases. The project will be coordinated at the Helmholtz Zentrum München, where about 500,000 euros of the funding will remain.

© Fotolia/ktsdesign

For more information, please click here: https://www.helmholtz-muenchen.de/en/news/latest-news/press-information-news/article/43651/index.html